KiWuC: Effects of Fasting on Success Rates of Assisted Reproductive Techologies

Sponsor
Charite University, Berlin, Germany (Other)
Overall Status
Recruiting
CT.gov ID
NCT04998591
Collaborator
Karl and Veronica Carstens Foundation (Other)
32
1
2
15.9
2

Study Details

Study Description

Brief Summary

This exploratory study investigates fasting as a potential supportive therapy for infertility treatment in women undergoing in-vitro-fertilization (IVF) / intracystoplamsatic sperm injection (ICSI)

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Fasting
N/A

Detailed Description

This 2-arm, randomized, controlled exploratory clinical trial aims to explore fasting as a novel supportive treatment in female infertility during IVF / ICSI. The participants will be randomized in two groups: a fasting group and a waiting list. The intervention group follows a fasting intervention, whereas the patients on the waiting list continue their normal diet. All groups will be trained and accompanied by medical experts. In addition, qualitative interviews will be conducted including individual and focus group interviews with a subgroup of participants.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
32 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
This explorative study is conducted in form of a randomized, controlled trial design with a fasting intervention and a waiting list, which continues the usual diet.This explorative study is conducted in form of a randomized, controlled trial design with a fasting intervention and a waiting list, which continues the usual diet.
Masking:
Single (Outcomes Assessor)
Masking Description:
It is not possible to mask a fasting intervention for the participant or the study personel. Therefore only outcome assessors are masked.
Primary Purpose:
Treatment
Official Title:
Effects of Fasting on Success Rates of In-vitro-fertilization (IVF) / Intracytoplasmatic Sperm Injection (ICSI) in Women With Fertility Disorders
Actual Study Start Date :
Aug 3, 2021
Anticipated Primary Completion Date :
Dec 1, 2022
Anticipated Study Completion Date :
Dec 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Fasting group

Participants will be councelled and accompanied to follow a fasting regime of 7 days in an outpatient setting under medical supervision.

Behavioral: Fasting
fasting for 7 days (caloric intake <500 kcal in liquid form)
Other Names:
  • Prolonged Fasting
  • No Intervention: Waiting list

    This group maintains their individual diet during the whole time of the study. In case that the first cycle of In-Vitro-Fertilization fails, they are offered a fasting intervention before a next cycle.

    Outcome Measures

    Primary Outcome Measures

    1. Fertilisation rate [throughout 1-3 days after in-vitro-fertilization (IVF) / intracytoplasmatic sperm injection (ICSI)]

      Fertilisation rate of the retrieved oocytes

    Secondary Outcome Measures

    1. glucose in culture medium of oocytes [throughout 1-3 days after in vitro fertilisation]

      chemical composition of culture medium (glucose)

    2. lactate in culture medium of oocytes [throughout 1-3 days after in vitro fertilisation]

      chemical composition of culture medium (lactate)

    3. pyruvate in culture medium of oocytes [throughout 1-3 days after in vitro fertilisation]

      chemical composition of culture medium (pyruvate)

    4. pregnancy rate [4 weeks after IVF/ICSI]

      pregnancies after IVF/ICSI

    5. rate of mature oocytes [at IVF / ICSI intervention]

      rate of mature oocytes

    6. rate of life births [10 months after IVF/ICSI]

      rate of life births after IVF/ICSI

    7. rate of implantable embryos [at IVF/ICSI]

      rate of implantable embryos after the IVF/ICSI

    8. Course of IVF/ICSI preparation and pregnancy [4 weeks and 10 months after IVF / ICSI]

      Course of IVF/ICSI preparation and pregnancy

    9. WHO-5 questionnaire [baseline, within one week before IVF, 4 weeks after IVF, 10 months after baseline]

      Quality of life

    10. changes in diet [baseline, within one week before IVF, 4 weeks after IVF, 10 months after baseline]

      self-developed questionnaire to examine dietary behaviour

    11. mindfulness [baseline, within one week before IVF, 4 weeks after IVF, 10 months after baseline]

      MAAS-questionnaire, validated questionnaire to examine mindfulness

    12. anxiety and depression [baseline, within one week before IVF, 4 weeks after IVF, 10 months after baseline]

      HADS-questionnaire, validated questionnaire to examine anxiety and depression

    13. current mood [baseline, within one week before IVF, 4 weeks after IVF, 10 months after baseline]

      ASTS-questionnaire, validated questionnaire to examine current mood

    14. experienced stress [baseline, within one week before IVF, 4 weeks after IVF, 10 months after baseline]

      Cohen-stress scale, validated questionnaire to examine experienced stress

    15. physical fitness [baseline, within one week before IVF, 4 weeks after IVF, 10 months after baseline]

      questionnaire to examine physical fitness

    16. quality of relationship [baseline, within one week before IVF, 4 weeks after IVF, 10 months after baseline]

      self-developed questionnaire to examine the relationship between the two partners desiring to have a child

    17. psychological stress caused by the unfulfilled desire to have children [baseline, within one week before IVF, 4 weeks after IVF, 10 months after baseline]

      self-developed questionnaire to examine the psychological stress caused by the unfulfilled desire to have children

    18. gratitude [baseline, within one week before IVF, 4 weeks after IVF, 10 months after baseline]

      validated questionnaire to examine gratitude

    19. self-efficacy [baseline, within one week before IVF, 4 weeks after IVF, 10 months after baseline]

      ASKU, validated questionnaire to examine self-efficacy

    20. abdominal sonography [within 1 month before, during and within 2 weeks after the fasting intervention]

      sonography in a subgroup

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    25 Years to 38 Years
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Women aged 25 to 38 years with planned IVF / ICSI

    • 1 ng/ml ≤ Anti-Mullerian Hormone (AMH) ≤ 4 ng/ml

    • Unfulfilled desire to have children >1 year

    • 25 kg/m² ≤ BMI ≤ 35 kg/m² declaration of consent

    Exclusion Criteria:
    • Language barriers

    • Previously known serious mental illness or cognitive impairment

    • Patients with anatomical/organic damage and proven uterine abnormalities

    • Eating disorders in the medical history

    • Serious previous internal diseases

    • Lack of internet access

    • No consent to randomisation

    • Participation in other studies

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Hochschulambulanz für Naturheilkunde der Charité-Universitätsmedizin Berlin Berlin Germany 14109

    Sponsors and Collaborators

    • Charite University, Berlin, Germany
    • Karl and Veronica Carstens Foundation

    Investigators

    • Principal Investigator: Andreas Michalsen, Prof. Dr., Charite University, Berlin, Germany

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Andreas Michalsen, Prof. Dr. med., Charite University, Berlin, Germany
    ClinicalTrials.gov Identifier:
    NCT04998591
    Other Study ID Numbers:
    • KiWuC
    First Posted:
    Aug 10, 2021
    Last Update Posted:
    Aug 10, 2021
    Last Verified:
    Aug 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    Yes
    Plan to Share IPD:
    Yes
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Andreas Michalsen, Prof. Dr. med., Charite University, Berlin, Germany
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 10, 2021